Chinese Network of Pediatric Antiretroviral Therapy (CN-PART)
This study is currently recruiting participants.
(see Contacts and Locations)
Verified November 2013 by National Center for AIDS/STD Control and Prevention, China CDC
Sponsor:
National Center for AIDS/STD Control and Prevention, China CDC
Information provided by (Responsible Party):
National Center for AIDS/STD Control and Prevention, China CDC
ClinicalTrials.gov Identifier:
NCT01210924
First received: September 27, 2010
Last updated: November 20, 2013
Last verified: November 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This is an observational cohort in pediatric HIV patients in China. Children who receive antiretroviral drugs will be recruited in this study. The main objectives are as follows: 1. To establish simpler and smarter pediatric antiretroviral therapy in China including both first-line and second-line regimens. 2. To study the nature, characteristics and mechanisms of immunoreconstitution in HIV-infected children using the data and samples from the pediatric antiretroviral therapy cohort. 3. To establish a basic science and clinical research network based on the pediatric antiretroviral cohort.
| Condition |
|---|
|
Acquired Immunodeficiency Syndrome |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Chinese Study of Pediatric Antiretroviral Therapy |
Resource links provided by NLM:
Further study details as provided by National Center for AIDS/STD Control and Prevention, China CDC:
Biospecimen Retention: Samples With DNA
plamsa, PMBC, whole blood
| Estimated Enrollment: | 400 |
| Study Start Date: | April 2010 |
| Estimated Study Completion Date: | December 2015 |
| Estimated Primary Completion Date: | December 2015 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
| Pediatric ART patients |
Eligibility| Ages Eligible for Study: | up to 15 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
Pediatric HIV-infected patients receiving triple antiretroviral drugs
Criteria
Inclusion Criteria:
- clinical diagnosis of HIV infection
- receiving triple antiretroviral drugs
Exclusion Criteria:
- clinical status not stable
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01210924
Please refer to this study by its ClinicalTrials.gov identifier: NCT01210924
Contacts
| Contact: Fujie Zhang, MD | +861063039086 | treatment@chinaaids.cn | |
| Contact: Yan Zhao, MD | +861063039075 | zhaoyanmgl@yahoo.com.cn |
Locations
| China | |
| National Center for AIDS/STD Control and Prevention, China Center for Disease Control and Prevention | Recruiting |
| Beijing, China, 102206 | |
| Contact: Yan Zhao, MD +861063039075 zhaoyanmgl@yahoo.com.cn | |
| Principal Investigator: Fujie Zhang, MD | |
Sponsors and Collaborators
National Center for AIDS/STD Control and Prevention, China CDC
Investigators
| Principal Investigator: | Fujie Zhang, MD | National Center for AIDS/STD control and prevention |
More Information
No publications provided
| Responsible Party: | National Center for AIDS/STD Control and Prevention, China CDC |
| ClinicalTrials.gov Identifier: | NCT01210924 History of Changes |
| Other Study ID Numbers: | Pediatric treatment 2010, 2008ZX10001-007 |
| Study First Received: | September 27, 2010 |
| Last Updated: | November 20, 2013 |
| Health Authority: | China: Ministry of Health |
Keywords provided by National Center for AIDS/STD Control and Prevention, China CDC:
|
children Acquired Immunodeficiency Syndrome antiretroviral therapy China Mortality |
Additional relevant MeSH terms:
|
Acquired Immunodeficiency Syndrome HIV Infections Immunologic Deficiency Syndromes Syndrome Disease Immune System Diseases Lentivirus Infections |
Pathologic Processes RNA Virus Infections Retroviridae Infections Sexually Transmitted Diseases Sexually Transmitted Diseases, Viral Slow Virus Diseases Virus Diseases |
ClinicalTrials.gov processed this record on February 25, 2015